Bionano Genomics is an American life sciences instrumentation company in the genome analysis space. It was founded in 2003 and is headquartered in San Diego, California.
P/E
Net profit
P/B
Book value
P/FCF
FCF
Yield
Growth potential
Bionano Genomics news
06.05.2022
Bionano Genomics' GAAP loss for 3 months of 2022 was $29.952 million, a three-fold increase from $9.947 million in the previous year. Revenue increased 79.8% to $5.696 million from $3.168 million a year earlier.
Source: 
ir.bionanogenomics.com
ir.bionanogenomics.com
02.03.2022
Bionano Genomics reported a GAAP loss of $72.435 million for 2021, up 76.2% from $41.106 million in the previous year. Revenue increased 2.1-fold to $17.981 million from $8.503 million a year earlier.
Source: ir.bionanogenomics.com
ir.bionanogenomics.com
05.11.2021
Bionano Genomics reported a GAAP loss of $49.486 million for 9M 2021, up 68.5% from $29.376 million in the previous year. Revenues increased 2.6 times to $11.679 million from $4.513 million a year earlier.
Source: ir.bionanogenomics.com
ir.bionanogenomics.com
04.08.2021
Bionano Genomics reported a GAAP loss of $28.733 million for the six months of 2021, up 54.6% from $18.584 million in the previous year. Revenue tripled to $7,024 million from $2,318 million a year earlier.
Source: ir.bionanogenomics.com
ir.bionanogenomics.com
General information
| Company name | Bionano Genomics |
|---|---|
| Tags | #medical equipment |
| Sector | Health Care / Pharmaceuticals, Biotechnology & Life Sciences / Life Sciences Tools & Services / Life Sciences Tools & Services |
| Business address | 9540 Towne Centre Drive Suite 100 San Diego, CA 92121 United States |
| Mailing address | 9540 Towne Centre Drive Suite 100 San Diego, CA 92121 United States |
| Website | ir.bionanogenomics.com |
| Information disclosure | www.sec.gov |
English (US) 